Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder

被引：0
|
作者：
De Hert, M.
Kalnicka, D.
van Winkel, R.
Wampers, M.
Hanssens, L.
Van Eyck, D.
Scheen, A.
Peuskens, J.
机构：
[1] Katholieke Univ Leuven, Ctr Psychiat, Kortenberg, Belgium
[2] Charles Univ Prague, Dept Psychiat, Med Fac Hradec, Kralove, Czech Republic
[3] Univ Liege, Dept Epidemiol & Publ Hlth, Liege, Belgium
[4] Univ Liege, Dept Diabet Nutr & Metab Disorders, CHU Sart Tilman, Liege, Belgium
来源：
DRUG SAFETY | 2006年 / 29卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
178
引用
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [31] Trauma and Posttraumatic Stress Disorder (PTSD) in Patients with Schizophrenia or Schizoaffective Disorder
    Lommen, Miriam J. J.
    Restifo, Kathleen
    COMMUNITY MENTAL HEALTH JOURNAL, 2009, 45 (06) : 485 - 496
  • [32] Trauma and Posttraumatic Stress Disorder (PTSD) in Patients with Schizophrenia or Schizoaffective Disorder
    Miriam J. J. Lommen
    Kathleen Restifo
    Community Mental Health Journal, 2009, 45 : 485 - 496
  • [33] Executive functioning deficits in patients with schizophrenia, schizoaffective disorder, and bipolar disorder
    Balser, LA
    Wood, J
    Nimgaonkar, VL
    Pogue-Geile, MF
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 21S - 22S
  • [34] Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder
    Pagel, Tobias
    Baldessarini, Ross J.
    Franklin, Jeremy
    Baethge, Christopher
    BIPOLAR DISORDERS, 2013, 15 (03) : 229 - 239
  • [35] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 491 - 491
  • [36] Comorbid depression and treatment attitude among out-patients with schizophrenia or schizoaffective disorder
    Frikha, A.
    Brahem, S.
    Mhalla, A.
    Mlika, S.
    Ben Nasr, S.
    Ali, B. Ben Hadj
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S498 - S498
  • [37] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    Hill, AL
    Tollefson, GD
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 185S - 186S
  • [38] Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response
    Lindenmayer, Jean-Pierre
    Liu-Seifert, Hong
    Kulkarni, Pandurang M.
    Kinon, Bruce J.
    Stauffer, Virginia
    Edwards, Sara E.
    Chen, Lei
    Adams, David H.
    Ascher-Svanum, Haya
    Buckley, Peter F.
    Citrome, Leslie
    Volavka, Jan
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (07) : 990 - 996
  • [39] Ziprasidone: An overview of efficacy and tolerability in the treatment of patients with an acute exacerbation of schizophrenia or schizoaffective disorder
    Keck, PE
    Harrigan, EP
    Reeves, KR
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 535 - 535
  • [40] Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder
    Howes, Oliver D.
    Wheeler, Michael J.
    Pilowsky, Lyn S.
    Landau, Sabine
    Murray, Robin M.
    Smith, Shubulade
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (03) : 361 - 367
12345